Opportunity

SAM #PANHCA26P0000031152

Sole Source Contract Modification for Chemistry/Immunochemistry Analyzers and Supplies at Fort Jackson, SC

Buyer

Defense Health Agency

Posted

August 19, 2026

Respond By

September 02, 2026

Identifier

PANHCA26P0000031152

NAICS

325413

This notice announces the Defense Health Agency's intent to modify an existing sole source contract with Abbott Laboratories for Moncrief Army Health Clinic at Fort Jackson, SC. - Agency: Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) - Location: Moncrief Army Health Clinic, Fort Jackson, South Carolina - Contract: Sole source modification to Firm-Fixed-Price, commercial Cost-Per-Reportable-Result (CPRR) contract (W91YTZ25C0003) - Vendor/OEM: Abbott Laboratories, Inc. - Scope: - Increase estimated quantities and ceiling funding for Option years 1-4 - Products/services: Chemistry/Immunochemistry analyzers, reagents, consumables, calibrations, and control material - Requirements: - Sole source justification: Only Abbott Laboratories can meet agency needs - Out-of-scope bilateral modification to existing contract - NAICS: 325413 (In-vitro diagnostic substances manufacturing) - PSC: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits and Sets) - No specific part numbers or quantities provided - Commercial opportunity for similar OEMs is limited due to sole source determination

Description

Notice of Intent to Sole Source

This notice is being published in accordance with Revolutionary FAR Overhaul (RFO) Federal Acquisition Regulation (FAR) Subpart 5.101 requiring dissemination of information for proposed contract actions. This is a Notice of Intent to Sole Source and is not a request for competitive quotes/proposals. 

The Defense Health Agency Contracting Activity Healthcare Contracting Division, Southeast (DHACA-HCD-SE) is issuing this Notice of Intent (NOI) to inform industry contractors of the Government’s intent to execute a Sole Source out-of-scope bilateral modification to an existing Firm-Fixed-Price, commercial Cost-Per-Reportable-Result (CPRR) contract, W91YTZ25C0003, awarded to Abbott Laboratories, Inc., for Moncrief Army Health Clinic, Fort Jackson, South Carolina. In accordance with RFO FAR 6.103-1, Only one responsible source and no other supplies or services will satisfy agency requirements. 

This contract action is to increase the estimated quantities and overall ceiling funding for Option years 1, 2, 3, and 4 for Chemistry/Immunochemistry analyzers, reagents, consumables, calibrations, and control material, in support of Defense Health Agency and Department of the Army mission. 

The North American Industry Classification System (NAICS) for this requirement is 325413, In-vitro diagnostic substances manufacturing. The Small Business Administration (SBA) size standard is 1,250 employees. The Product/Service Code (PSC) is 6550, In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. 

This NOI is neither a formal solicitation, nor a request for competitive proposals. No solicitation document is available, and telephone requests will not be honored. No award will be made based on unsolicited quotations or offers received in response to this notice. Any response to this notice must show clear, compelling, and convincing evidence that competition will be advantageous to the Government. The intent of this synopsis is for informational purposes only. Information received will normally be considered solely for the purpose of determining whether to conduct competitive procurement. A determination by the Government to not compete this action based on this notice is solely within the discretion of the Government. All inquiries and concerns must be addressed in writing via email to Donna Rodriguez, email: donna.d.rodriguez.civ@health.mil and Mary Shifflett, email: mary.e.shifflett2.civ@health.mil.  

All interested parties who are responsible, certified, and capable may identify their interest and may submit a Capabilities Statement on company letterhead no later than 12:00 P.M., Eastern Daylight Time (EDT), on September 2, 2026, to the above listed contacts. The interested parties bear full responsibility to ensure complete, timely transmission and confirmation of receipt. 

View original listing